Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995
Next-Day Memory Impairment with Triazolam Use
Lancet 337:827-831, Bixler,E.O.,et al, 1991
Adverse Drug Reactions Associated with Global Cognitive Impairment in Elderly Persons
Ann Int Med 107:169-173, Larson,E.B.,et al, 1987
An unusual neuropsychiatric manifestation of systemic lupus erythematosus
Neurol 90:e1929-e1932, Dongkyung, D.,et al, 2018
The Alcohol Withdrawal Syndrome
JNNP 79:854-862, McKeon,A.,et al., 2008
Complications of Sedation with Midazolam in the Intensive Care Unit and a Comparison with Other Sedative Regimens
Crit Care Med 26:947-956, Shafer,A., 1998
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
The Poisoned Patient with Altered Consciousness, Controversies in the Use of a"Coma Cocktail"
JAMA 274:562-569, Hoffman,R.S.&Goldfrank,L.R., 1995
Elevated Brain Concentrations of 1, 4-Benzodiazepines in Fulminant Hepatic Failure
NEJM 325:473-478, 5091991., Basile,A.S.,et al, 1991
"Endogenous"Benzodiazepine Activity in Body Fluids of Patients with Hepatic Encephalopathy
Lancet 336:81-83, Mullen,K.D.,et al, 1990
Delirium in the Elderly Patient
NEJM 320:578-582, Lipowski,Z.J., 1989
Traveler's Amnesia, Transient Global Amnesia Secondary to Triazolam
JAMA 258:945-946, Morris,H.H.&Estes,M.L., 1987